NASDAQ: FBRXForte Biosciences Inc Stock Ownership - Who owns Forte Biosciences?
Insider buying vs selling
Have Forte Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul A. Wagner | CEO Secretary and Chair of the Board | 2025-07-01 | 98 | $12.44 | $1.22kSell |
| Antony A. Riley | CHIEF FINANCIAL OFFICER | 2025-07-01 | 134 | $12.44 | $1.67kSell |
| Paul A. Wagner | CEO Secretary and Chair of the Board | 2025-04-01 | 18 | $7.43 | $133.74Sell |
| Antony A. Riley | CHIEF FINANCIAL OFFICER | 2025-04-01 | 154 | $7.43 | $1.14kSell |
| Antony A. Riley | CHIEF FINANCIAL OFFICER | 2025-01-01 | 154 | $22.71 | $3.50kSell |
| Paul A. Wagner | CEO Secretary and Chair of the Board | 2025-01-01 | 164 | $22.71 | $3.72kSell |
| Antony A. Riley | CHIEF FINANCIAL OFFICER | 2024-11-21 | 22,514 | $5.55 | $125.00kBuy |
| Paul A. Wagner | CEO Secretary and Chair of the Board | 2024-10-01 | 98 | $5.16 | $505.68Sell |
| Antony A. Riley | CHIEF FINANCIAL OFFICER | 2024-10-01 | 133 | $5.16 | $686.28Sell |
FBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when FBRX insiders and whales buy or sell their stock.
FBRX Shareholders
What type of owners hold Forte Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Steven Michael Oliveira | 62.88% | 4,139,450 | $56.54M | Insider |
| Janus Henderson Group PLC | 13.97% | 920,000 | $12.57M | Institution |
| Fred Alger Management LLC | 13.83% | 910,609 | $12.44M | Institution |
| Tybourne Capital Management Hk Ltd | 9.42% | 619,981 | $8.47M | Institution |
| Ikarian Capital LLC | 9.25% | 609,225 | $8.32M | Institution |
| Bvf Inc | 9.03% | 594,282 | $8.12M | Institution |
| Orbimed Advisors LLC | 9.01% | 593,088 | $8.10M | Institution |
| Harry E. Gruber | 6.71% | 441,438 | $6.03M | Insider |
| Douglas Jolly | 6.64% | 436,956 | $5.97M | Insider |
| Dennis N. Berman | 3.74% | 246,376 | $3.37M | Insider |
FBRX vs Biotech Stocks
Forte Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.